Clinical Trials Update: Jan. 5, 2007
Diabetes - Type 2 Constipation Crohn's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetes - Type 2
This is a clinical trial of investigational inhaled insulin for people with diabetes type 2. Non-smokers 18-80 who have been diagnosed with type 2 diabetes for at least six months, are currently not using insulin, and are taking Glucophage plus one other oral anti-diabetic drug may be eligible. The study includes approximately eight clinic visits over seven months.
The research site is in Denver, Colo.
This study will evaluate an investigational drug, linaclotide acetate, to treat chronic constipation. Volunteers at least 18 may be included who have fewer than three spontaneous bowel movements per week and have met any of the following symptoms for 12 weeks in the prior year: straining to produce bowel movements, lumpy or hard stools, and sensation of incomplete evacuation. Additional criteria apply.
The research sites are located across the United States.
This research study is for adults over age 18 with moderate-to-severe Crohn's disease. Qualified participants will receive study related care and study medication at no cost, and will be compensated for time and travel.
The research site is in Raleigh, NC.
Copyright 2007 Thomson CenterWatch. All rights reserved.